Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab

  • Technology appraisal guidance
  • TA357
  • Published: 
  • Last updated: 
Download guidance (PDF)

Update information

September 2017: Reference to a patient access scheme in section 1.1 has been replaced with details of a commercial access agreement. Section 2.3 has been updated with the same information.

ISBN: 978-1-4731-1465-4